MUC2 and neoplasm: Increased expression of MUC2 was associated with better OS in lower GI tumors adjusted for age, stage, tumor type (colon/appendix), and stratified by study site (HR 0.72; 0.55–0.95; P = 0.020; Supplementary Table S5).